Skip to main content

Table 1 Demographic and clinical characteristics of the study population at the first follow-up visit

From: A retrospective database study of the demographic features and glycemic control of patients with type 2 diabetes in Kinshasa, Democratic Republic of the Congo

  

Study population (N = 8976; 100%)

Women (N = 6043; 67%)

Men (N = 2933; 33%)

Demographic characteristics

Age mean ± SD

Missing data (1.1%)

Years

55.2 ± 11.3

54.8 ± 11.1

56.1 ± 11.7

Age classification n (%)

Missing data (1.1%)

< 40 years

752 (8.5)

521 (8.7)

231 (8.0)

40–65 years

6248 (70.4)

4294 (71.9)

1954 (67.3)

> 65 years

1873 (21.1)

1157 (19.4)

716 (24.7)

Diabetes details

Time since diagnosis n (%)

Missing data (0.9%)

< 5 years

2379 (26.7)

1595 (26.6)

784 (27.0)

5–10 years

4364 (49.1)

2938 (49.1)

1426 (49.1)

11–20 years

2000 (22.5)

1369 (22.9)

631 (21.7)

> 21 years

149 (1.7)

84 (1.4)

65 (2.2)

Visits*

Median [IQR]

Number of visits

3 [2–6]

3 [2–6]

3 [2–5]

Length of follow-up*

Median [IQR]

Years follow-up

1.8 [0.5–3.4]

1.9 [0.6–3.4]

1.6 [0.4–3.2]

Initial treatment n (%)

Missing data (0.0%)+

OGLDs~

2949 (32.9)

2066 (34.2)

889 (30.1)

Insulin~

5075 (56.5)

3320 (54.9)

1755 (59.8)

Diet

296 (3.3)

195 (3.2)

101 (3.5)

OGLDs + Insulin~

656 (7.3)

462 (7.7)

194 (6.6)

Anthropometry

Weight mean ± SD

Missing data (2.7%)

kg

69.2 ± 14.5

69.0 ± 14.8

69.4 ± 13.9

Height mean ± SD

Missing data (2.0%)

Metres

1.6 ± 0.1

1.6 ± 0.1

1.7 ± 0.1

BMI mean ± SD

Missing data (4.8%)

kg/m2

25.9 ± 5.2

26.8 ± 5.5

24.1 ± 4.2

BMI classification n (%)

Missing data (4.8%)

Underweight/normal (< 24.9)

3606 (42.0)

2045 (35.3)

1561 (56.1)

Overweight (25–29.9)

3144 (36.7)

2164 (37.3)

980 (35.3)

Obese (≥ 30)

1827 (21.3)

1587 (27.4)

240 (8.6)

Clinical parameters

Systolic blood pressure mean ± SD

Missing data (1.1%)

mmHg

131.5 ± 24.1

132.7 ± 24.6

129.2 ± 23.0

Systolic blood pressure n (%)

Missing data (1.1%)

Normal (< 130 mmHg)

4022 (45.3)

2610 (43.7)

1412 (48.8)

Elevated (≥130 < 140 mmHg)

1280 (14.4)

869 (14.5)

411 (14.2)

High (≥140 mmHg)

3574 (40.3)

2502 (41.8)

1072 (37.0)

Diastolic blood pressure mean ± SD

Missing data (1.1%)

mmHg

78.9 ± 13.5

79.4 ± 13.7

77.7 ± 12.9

FPG*

missing data (0.0%)+ median [IQR]

mg/dL

199 [135–299]

199 [136–297]

199 [133–303]

Glycemic target n (%)

Missing data (0.0%)+

Achieved (FPG < 126 mg/dL)

1807 (20.1)

1201 (19.9)

606 (20.1)

 

Unachieved (FPG ≥ 126 mg/dL)

7169 (79.9)

4842 (80.1)

2327 (79.3)

  1. Abbreviations: BMI body mass index, FPG fasting plasma glucose, IQR interquartile range, OGLDs oral glucose lowering drugs
  2. *Values are not normally distributed, therefore, medians and IQR are reported
  3. +Missing data equals 0.0% as patients’ information was excluded if any of the following information was not available at the first follow-up visit: date of the visit, sex, glycemic value, and treatment
  4. ~The most frequently used type of OGLDs were Metformin and Daonil. For insulin, it varied between mixed, rapid-acting, long-acting, and intermediate-acting insulin